CUSIX
Price
$15.67
Change
+$0.02 (+0.13%)
Updated
Aug 21 closing price
Net Assets
10.01M
DFFVX
Price
$44.63
Change
+$0.33 (+0.74%)
Updated
Aug 21 closing price
Net Assets
17.07B
Interact to see
Advertisement

CUSIX vs DFFVX

CUSIX vs DFFVX Comparison Chart in %
View a ticker or compare two or three
VS
CUSIX vs. DFFVX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUSIX is a Hold and DFFVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 17.1B vs. CUSIX (10M). DFFVX pays higher dividends than CUSIX: DFFVX (1.49) vs CUSIX (1.28). CUSIX was incepted earlier than DFFVX: CUSIX (17 years) vs DFFVX (27 years). CUSIX (4.22) is less costly to investors than DFFVX (0.30). CUSIX is a more actively managed with annual turnover of: 38.00 vs. DFFVX (10.00). DFFVX has a lower initial minimum investment than CUSIX: DFFVX (0) vs CUSIX (1000000). DFFVX annual gain was more profitable for investors over the last year : 29.71 vs. CUSIX (13.15). DFFVX return over 5 years is better than : 60.33 vs. CUSIX (7.20).
CUSIXDFFVXCUSIX / DFFVX
Total Expense Ratio1.000.29345%
Annual Report Gross Expense Ratio4.220.301,407%
Fund Existence17 years27 years-
Gain YTD13.72521.67063%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10M17.1B0%
Annual Yield % from dividends1.281.4986%
Returns for 1 year13.1529.7144%
Returns for 3 years27.6061.8845%
Returns for 5 years7.2060.3312%
Returns for 10 years34.34120.1329%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX23.980.24
+1.01%
Saratoga Health & Biotechnology A
GQJIX12.860.08
+0.63%
GQG Partners Intl Qual Val Fd Ins
DMCFX32.440.17
+0.53%
Invesco Discovery Mid Cap Growth R5
GRMIX34.660.15
+0.43%
Nationwide S&P 500 Index R6
TNXIX23.190.09
+0.41%
1290 Avantis U.S. Large Cap Growth I